A B S T R A C T Urinary excretion of hydroxyproline (Hyp) is one index of total collagen degradation, from all sources. Since some of the Hyp released from collagen may be further metabolized before it is excreted, other markers are necessary to measure collagen breakdown. Excretion of the glycosides of hydroxylysine (Hyl), glucosyl galactosyl hydroxylysine (Hyl[GlcGal ]), and galactosyl hydroxylysine (Hyl-[Gal]), more accurately reflects collagen metabolism since these products occur in specific ratios in different tissue collagens and are themselves metabolized only to a minor degree.
A B S T R A C T Urinary excretion of hydroxyproline (Hyp) is one index of total collagen degradation, from all sources. Since some of the Hyp released from collagen may be further metabolized before it is excreted, other markers are necessary to measure collagen breakdown. Excretion of the glycosides of hydroxylysine (Hyl), glucosyl galactosyl hydroxylysine (Hyl [GlcGal ] ), and galactosyl hydroxylysine (Hyl- [Gal] ), more accurately reflects collagen metabolism since these products occur in specific ratios in different tissue collagens and are themselves metabolized only to a minor degree.
The ratios of total Hyl/Hyp and Hyl(GlcGal)/Hyl-(Gal) were measured in the urine of normal subjects and of patients with Paget's disease of bone, hyperphosphatasia, and extensive thermal burns. In patients with extensive thermal bums the pattern of urinary Hyl and its glycosides was consistent with degradation of collagen in dermis and fascia. When bone collagen degradation was dominant, the pattern of urinary metabolites reflected that source. Pagetic bone collagen has an amino acid composition similar to normal bone and Hyl(GlcGal) 
INTRODUCTION
Collagens contain uinique, modified amino acids, the most abundant of which is 4-hydroxyproline (Hyp).2 Measurement of urinary excretion of total Hyp (free Hyp plus Hyp-containing peptides) has been used extensively as an index of collagen degradation (1) . It is not possible to obtain quantitative estimations of collagen breakdown by this measurement since most ofthe free Hyp is further metabolized to carbon dioxide and other products not incluided in the Hyp determination and only a portion appears in the urine. Woessner found that less than 15% of the Hyp of degraded collagen appears in the urine of the pospartum rat (2) . Weiss and Klein (3) determined that when collagen peptides were administered to rats, 75% were metabolized to respiratory carbon dioxide and 25% excreted. In their studies of a patient with deficiency in Hyp oxidase (hydroxyprolinemia), Efron et al. (4) found that only 20% of the urinary Hyp was peptide bound whereas 80% was free. An additional deficiency in the use of measurement of Hyp excretion to assess collagen degradation is that its estimation provides no information concerning the source of collagen since its content varies little from one tissue collagen to another.
Hydroxylysine (Hyl) is another amino acid unique to collagens and proteins containing collagen-like sequences. Like Hyp, Hyl is not reutilized for collagen biosynthesis and although it is considerably less abundant than Hyp, it is a potential marker for collagen metabolism. A variable proportion of Hyl residues in collagen are glycosylated as 38-1-galactosyl-0-hydroxylysine (Hyl [Gal] ) and some of these residues may be glucosylated as a-1-2-glucosyl-galactosyl-0-hydroxylysine (Hyl[GlcGal]) (5, 6) . The relative proportion and total content of glycosylated Hyl are different for different collagens. For example the ratio Hyl(GlcGal)/Hyl(Gal) is 0.47±0.09 in human bone, but 2.06±0.47 in human skin (7). Cunningham et al. (5) and Kakimoto and Akazawa (8) identified these Hyl glycosides in normal human urine and Segrest and Cunningham (9) suggested that since they were not metabolized to the same extent as Hyp, they could serve as more quantitative markers for collagen breakdown as well as provide information as to the source of the collagen metabolites.
In the present study we have measured the urinary excretion of Hyp, Hyl, and Hyl glycosides in normal subjects and patients with accelerated collagen breakdown, particularly in disorders of the skeleton, to determine relative contributions of different collagenous tissues to the urinary pool of collagen degradation products. At high rates of bone collagen breakdown the excretion of Hyl and Hyl glycosides reflects the major contribution of bone collagen, but at low rates of turnover, induced by agents which suppress bone resorption, the contribution of components other than bone and skin becomes evident.
METHODS
Sample collection. All 24-h urine samples were collected after the subjects had been on a low gelatin diet for at least 24 h. In some instances only first morning postabsorptive urinary samples were obtained. Samples were stored under toluene at 2-50C and when collections were completed they were filtered and kept at -20°C. Samples were freezedried either before or after storage at -20°C. 24-h urine samples were obtained from 21 untreated subjects with Paget's disease of bone. Five of these subjects were subsequently treated with the diphosphonate disodium etidronate (EHDP) (10) at doses of [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] mg/kg for up to 12 mo and urine samples were again collected at 3-6 mo intervals. Four subjects with Paget's disease were treated with 50-200 Medical Research Council (MRC) U per day of salmon calcitonin (11) for [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] mo; pre and post-treatment urinary samples were collected from these individuals at various intervals. Five pagetic and two normal control subjects were given single intravenous or subcutaneous injections of calcitonin and urines collected at 30-60 min intervals. 24-h urine samples were collected from four patients with bums covering an estimated 50-88% of body surface. Multiple urine samples from two subjects with hereditary hyperphosphatasia were supplied through the courtesy of Dr. Melvin Horwith (New York Hospital-Cornell Medical Center, New York). 12-h specimens were collected before and during human calcitonin therapy in one of these. Samples of bone from pagetic and normal subjects were obtained at time of hip surgery for pagetic coxopathy or at necropsy. Fascia and skin were obtained at necropsy from two additional subjects who did not have obvious disease of collagenous tissues.
Preparation of samples
Bone. Fragments ofnormal and pagetic bone were cleaned and stripped of periosteum. Specimens were demineralized with three changes of 0.5 M disodium EDTA in 0.1 M Tris-HCI, pH 8.0, 20 ml/g of tissue, over a period of 3 days, at 50C with constant agitation by means of a magnetic stirrer (7) . The samples were rinsed with distilled water and freeze-dried. No Hyl or Hyp was found on amino acid analysis of acid hydrolysates of the supematant solutions.
Skin. Fat and hair were stripped by dissection and the skin placed in 2 M NaBr at 20°C for 12 h, allowing the epidermis to be peeled away from the dermis (12, 13) . The dermis was rinsed with distilled water and freezedried.
Fascia. Any muscle was stripped off by dissection and the fascia rinsed with distilled water and freeze-dried.
Analysis of total Hyl and Hyp. Samples of bone, skin, and fascia (approximately 8 mg dry weight) and 1-5 ml equivalents of freeze-dried urine were hydrolyzed under nitrogen in sealed tubes in constant boiling HCI at 108°C for 20 h. The samples were then dried in a desiccator containing solid NaOH under vacuum. Dried hydrolysates were quantitatively transferred with 0.1 N HCI to 5-ml volumetric flasks and brought to final volume. 500 ul of solution was used for amino acid anlysis. Quantitative amino acid analyses (14) were performed with a modified model 117 Beckman-Spinco automatic amino acid analyzer (Beckman Instruments Inc., Spinco Div., Palo Alto, Calif.).
Base hydrolysis and Hyl glycoside determination. Dry tissues (15-20 mg) and appropriate amounts of urine (7) (according to concentration) were used. Specimens were hydrolyzed in 2 N KOH in alkali-resistant boron-free hydrolysis tubes at 108°C for 20 h. The solutions were neutralized to pH 7with 1 M HCl04. Samples were centrifuged at 1,000 rpm at room temperature for 5 min; the supemates were removed and freeze-dried. Samples were quantitatively transferred to a Bio Gel P-2 (200-400 mesh) gel filtration column (100 x 1.8 cm) (Bio-Rad Laboratories, Richmond, Calif.) in a total of 2 ml of 0.1 N acetic acid. 150 fractions (each 2.2 ml) were collected with an LKB fraction collector (LKB Instruments Inc., Rockville, Md.). Fractions numbered 51-75 (containing Hyl and its glycosides) were pooled and freeze-dried. These were then placed on the amino acid analyzer column.
Other methods. Creatinine was determined by the method of Folin (15) Relationship of urinary Hyl to Hyp. In Fig. 1 28 .0 ,umol Hyp/mg creatinine). In patients with milder disease, both treated and untreated, the urinary ratio of Hyl/Hyp rose with decreasing excretion of Hyp. The highest values were reached in normal subjects given calcitonin acutely.
In Fig. 2 the data shown in Fig. 1 are replotted on a log-log scale to illustrate better the two components of the curve. A plateau is reached at levels of Hyp excretion greater than approximately 2 ,umol/mg creatinine. At very low values of Hyp the ratio is extrapolated to approximately 0.5-0.7.
Relationship of urinary Hyl(GlcGal) and Hyl(Gal) to Hyp. In Fig. 3 the molar ratio of urinary Hyl-(GlcGal)/Hyl(Gal) is plotted as a function of total urinary Hyp in normal subjects and untreated and treated patients with bone disease. The ratio fell with increasing levels of Hyp excretion, with a mean of 0.601±0.017 (SEM) at levels of urinary Hyp/ creatinine >2.0 umol/mg. The decrease in the ratio Hyl(GlcGal)/Hyl(Gal) is accounted for by a relatively larger contribution of Hyl(Gal) at the high excretions of Hyp. This is illustrated in Fig. 4 where the excretion of Hyl glycosides is plotted as a function of total Hyl excretion in treated and untreated patients with Paget's disease. The slope for the Hyl(Gal) data is steeper; therefore, at increasing concentrations of total Hyl in patients with Paget's disease, H/yp /Creafinine , mol/ mg FIGURE 3 The molar ratio of urinary Hyl(GlcGal)/Hyl(Gal) as a function of urinary total Hyp normalized to creatinine excretion (Hyp/creatinine) in same patient population described in Fig. 1 Five pagetic patients were given salmon calcitonin intravenously (8-20 gg) and acute changes measured.
All exhibited decreases in urinary Hyp (average 2.97 ,umol/mg creatinine) accompanied by increases in the ratio of Hyl(GlcGal)/Hyl(Gal) (average 0.25) and that of Hyl/Hyp (average 0.057). Within 2 h in one patient, urinary Hyp had fallen from 0.81 to 0.36 ,umol/mg creatinine, while the Hyl/Hyp ratio rose from 0.081 to 1.30 and the Hyl(GlcGal)/Hyl(Gal) ratio rose from 0.66 to 0.94. A typical response is shown in Fig. 5 .
In Table III Table V, were vith EHDP showing progressive decline after 9 mo as predicted. Hyl/Hyp ratios were somewhat higher kg, an additional 3 mo of 20 mg/kg, and an addi-than expected and could be accounted for by a contribunio of 20 mg/kg. tion not only from dermis but from fascia which has a higher Hyl/Hyp ratio than skin (12) . Indeed, normal p excretion fell. These values are included in deep fascia obtained at necropsy from two additional shown in Figs. 1-4. normal subjects showed the ratio of Hyl/Hyp to be g. 6 the effect of therapy with EHDP is 0.074 and 0.068 and that of Hyl(GlcGal)/Hyl(Gal) to d to that with salmon calcitonin on the urinary be 1.35 and 1.89. excretion of Hyl glycosides by two paients with Paget's disease. In both treatments there was a more profound decline in Hyl(Gal) than in Hyl(GlcGal). However the values for both therapies fell along similar curves.
Analysis of tissues from patients with Paget's disease. Since the patients with untreated Paget's disease had ratios of Hyl/Hyp and Hyl(GlcGal)/Hyl(Gal) in urine different from those in normal subjects, and since it is presumed that the collagen degradation products in pagetic patients are derived predominantly from bone, information on the composition of pagetic bone collagen is essential for interpretation of such data. Results of amino acid analysis and determination of Hyl and its glycosides in bone from five patients with Paget's disease are presented in Table IV . There was no significant difference in the amino acid composition of pagetic versus normal bone. The Hyl/Hyp ratio of pagetic bone was 0.050+0.010 DISCUSSION Since the Hyl glycosides were first isolated from urine by Cunningham et al. in 1967 (5) they have been found in both invertebrate (18) and vertebrate collagens (6, 19) . The urinary Hyl glycosides are metabolic products of endogenous collagen (19) , and their excretion roughly parallels excretion of Hyp in normal and diseased subjects.
There is previous evidence that measurements of urinary Hyl glycosides provide more accurate reflections ofcollagen degradation than measurements ofurinary Hyp (9, 20) . Segrest and Cunningham (9) calculated collagen turnover equivalents from urinary Hyl glycoside levels to be two to four times larger than those calculated from levels of urinary Hyp. Assuming that these estimations are accurate, Hyl glucoside excretion would account for 50-100% of degraded collagen. An (25) and that bone is the only other source with turnover of collagen breakdown products, a theoretical curve erphosphatasia for Hyl/Hyp as a function of total Hyp could be caltion during the culated (Fig. 7) . The observed data showed a reasonubsequent 12 h able fit with the calculated curve. Thus, it is possible ver, the Hyp/ but not proven that metabolism of Clq is responsible ined extremely for the high values for Hyl(GlcGal)/Hyl(Gal) seen in the untreated our patients when bone collagen degradation is supse in the ratios pressed. as observed.
An additional possible explanation for the increase e, both treated in the ratio of Hyl(GlcGal)/Hyl(Gal) is that the glycop and Hyl(Glc-sides may be derived from the higher molecular weight retion of Hyp. portion of the urinary collagen metabolites (retentate) ormal subjects which reflect new collagen synthesis (30) . Although 4roup, the Hyl/ the ratiO we have determined in preliminary studies, :han ten times 1.7, is higher than that of bone collagen, the presence [cGal)/Hyl(Gal) of this fraction alone cannot account for changes han that for skin in the composition of Hyl glycosides during treatts whose bone ment of Paget's disease, since the rise in that urinary a different pat-fraction accompanying therapy was of insufficient aled. Potential magnitude to affect the glycoside ratio. dlude cartilage
The results of therapy of Paget's disease with either llagens which calcitonin or EHDP are consistent with a specific I its glycosides, decrease in bone collagen resorption rather than ikely, however, collagen resorption in general. The relatively high gnificant rate.
urinary ratio of Hyl/Hyp in patients with extensive bcomponent of burns probably reflects involvement of collagenous ) daltons and is structures deep to the dermis such as fascia, which tly linked sub-have higher Hyl/Hyp ratios than the dermis. The results iol wt (25) (26) (27) . are thus consistent with other observations (12) 
